A perspective on the biotechnological potential of microalgae
Abstract
Microalgae are the untapped resource with more than 25,000 species of which only 15 are in use. In recent years, microalgal culture technology is a business oriented line owing to their different practical applications. Innovative processes and products have been introduced in microalgal biotechnology to produce vitamins, proteins, cosmetics, and health foods. For most of these applications, the market is still developing and the biotechnological use of microalgae will extend into new areas. With the development of sophisticated culture and screening techniques, microalgal biotechnology can meet the challenging demands of both the food and pharmaceutical industries. Genetic improvement should also play an important role in the future development of algal industries. Based on the preliminary research, several therapeutic benefits have been claimed for commercially produced microalgae including AIDS, cancer, and Cerebro vascular diseases. In near future, algal biomass will serve as a renewable energy source through commercial production of hydrocarbon by Botryococcus throughout the world.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The commercial production of microalgae is approximately 5,000 tons/year of dry matter.
“The commercial production of microalgae is approximately 5,000 tons/year of dry matter (Raja et al., 2008).”
From Microalgae Metabolites: A Rich Source for Food and Medicine (2019) · cites this paper as Raja et al., 2008
Microalgae are suitable sources of isotopically labeled compounds.
“Microalgae are one of the suitable sources of isotopically labeled compounds due to the ultimate choice to isolate stable isotopes from inorganic molecules, such as C-source, H-source and N-source, into high-value isotopic organic chemicals (Raja et al., 2008).”
From Microalgae Metabolites: A Rich Source for Food and Medicine (2019) · cites this paper as Raja et al., 2008
The citation lists haven’t been fetched yet
References 73 · Cited by 404
- Authors
- Raja, R., Hemaiswarya, S., Kumar, N. A., Sridhar, S., & Rengasamy, R.
- Affiliations
- University of Madras (IN)
- Indian Institute of Technology Madras (IN)
- Venue
- Critical Reviews in Microbiology
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 34
- Issue
- 2
- Pages
- 77-88
- ISSN
- 1040-841X (ISSN-L)
- 1549-7828
- OpenAlex
- W1965546023
- Semantic Scholar
- 93dca5eb52e0637c50d3a5edb8184ba83b68efcc
- Cited by
- 404
- References
- 73
- Citations by year
- 2026: 8 · 2025: 24 · 2024: 13 · 2023: 16 · 2022: 29 · 2021: 21 · 2020: 23 · 2019: 35 · 2018: 15 · 2017: 22 · 2016: 21 · 2015: 19 · 2014: 36 · 2013: 34 · 2012: 22
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Energy › Renewable Energy, Sustainability and the Environment › Algal biology and biofuel production
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Keywords
- microalgae, microalgal biotechnology, vitamins, microalgal proteins, cosmetics, health foods, pharmaceutical applications, Botryococcus, renewable energy, algal biomass
- MeSH terms
- Biodegradation, Environmental, Bioelectric Energy Sources, Biological Products, Biotechnology, Drug Industry, Fertilizers, Genetic Engineering, Industrial Waste, Infections, Biomass, Food Industry, Eukaryota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
